Alpha DNA Investment Management’s Truist Financial TFC Stock Holding History

Alpha DNA Investment Management’s Portfolio TFC Stock Details TFC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-55	Closed	-$3K	–	592
2021 Q1	$3K	Hold	55	–	–	﹤0.01%	514
2020 Q4	$2K	Buy	+55	New	+$2.49K	﹤0.01%	488

Other funds holding TFC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Alpha DNA Investment Management's TFC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Truist Financial (TFC) in Q2 2021, closing a stake of 55 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in TFC in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 1,351 funds tracked by Wall St. Rank hold TFC as of Q2 2021.

Alpha DNA Investment Management reported no remaining Truist Financial position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 55 Truist Financial shares in Q2 2021, an estimated $3K.
Alpha DNA Investment Management first reported a position in Truist Financial in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's Truist Financial position peaked at $3K in Q1 2021.
1,351 funds tracked by Wall St. Rank held Truist Financial as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.